Renate Marschon
Overview
Explore the profile of Renate Marschon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geissler K, Jager E, Barna A, Gurbisz M, Marschon R, Graf T, et al.
Eur J Haematol
. 2022 Mar;
109(1):50-57.
PMID: 35299281
Background: A multistep pathogenesis of myeloid leukemia including mutations in epigenetic, spliceosome, and signaling genes has been recently demonstrated in a preclinical model but is poorly validated in patients. Methods:...
2.
Machherndl-Spandl S, Jager E, Barna A, Gurbisz M, Marschon R, Graf T, et al.
Eur J Haematol
. 2021 May;
107(2):265-274.
PMID: 33998054
In older patients with chronic myelomonocytic leukaemia (CMML) and limited life expectancy due to age and or comorbidities, it is particularly important to consider the risk of transformation for individualised...
3.
Geissler K, Jager E, Barna A, Gurbisz M, Marschon R, Graf T, et al.
Wien Klin Wochenschr
. 2019 Jul;
131(17-18):410-418.
PMID: 31321531
In the Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) clinicolaboratory real-life data have been captured from 606 CMML patients from 14 different hospitals over the last 30 years. It is...
4.
Malli T, Rammer M, Haslinger S, Burghofer J, Burgstaller S, Boesmueller H, et al.
Mol Cytogenet
. 2018 Jan;
11:3.
PMID: 29344090
Background: Translocations of the locus on 14q32.3 are present in about 8% of patients with chronic lymphocytic leukemia (CLL) and contribute to leukemogenesis by deregulating the expression of the -partner...
5.
Malli T, Buxhofer-Ausch V, Rammer M, Erdel M, Kranewitter W, Rumpold H, et al.
Genes Chromosomes Cancer
. 2015 Sep;
55(1):60-8.
PMID: 26391436
Myeloid and lymphoid neoplasms with fibroblast growth factor receptor 1 (FGFR1) abnormalities, also known as 8p11 myeloproliferative syndrome (EMS), represent rare and aggressive disorders, associated with chromosomal aberrations that lead...
6.
Malli T, Duba H, Erdel M, Marschon R, Kranewitter W, Deutschbauer S, et al.
Am J Med Genet A
. 2014 Sep;
164A(12):3126-31.
PMID: 25250687
Here, we report on a male patient with developmental delay, speech impairment, mild dysmorphic features, and borderline intellectual disability, bearing a de novo balanced t(5;6)(q11;q25.3). By combining FISH and long...
7.
Bosmuller H, Haitchi-Petnehazy S, Webersinke G, Marschon R, Roithmeier F, Stummvoll W, et al.
Virchows Arch
. 2011 Jun;
459(2):183-91.
PMID: 21713364
Intratumoral immune cells and ERCC1 expression are likely to play a role in the response of ovarian carcinoma to chemotherapy, but their impact on therapy outcome is still unclear. Therefore,...
8.
Kralik J, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, et al.
Diagn Pathol
. 2011 Mar;
6:19.
PMID: 21401966
Background: Characterization of novel fusion genes in acute leukemia is important for gaining information about leukemia genesis. We describe the characterization of a new ETV6 fusion gene in acute myeloid...
9.
Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, et al.
J Vasc Surg
. 2005 May;
41(5):808-15.
PMID: 15886665
Objective: Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations are considered risk factors for venous thromboembolism. It remains to be characterized whether the presence of these...